Clinical trial
The Eosinophils Percentage Predicts In-hospital Major Adverse Cardiac Events in Patients With ST-elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention
NCT03740776 is registered in ClinicalTrials.gov with Dongying Zhang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Eosinophils Percentage Predicts In-hospital Major Adverse Cardiac Events in Patients With ST-elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention
- Lead sponsor
- Dongying Zhang
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2015
- Completion date
- November 1, 2018
- Enrollment
- 2 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.